First-in-human randomized study to assess the safety and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine based on ChAd155 viral vector expressing RSV viral proteins F, N and M2-1 in healthy adults
SNAPE M., CICCONI P., KLENERMAN P., JONES C., Sarkar E., DE LARA C., HUTCHINGS C.